Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cormedix Inc (CRMD)

8.96   -0.19 (-2.08%) 11-29 21:00
Open: 9.28 Pre. Close: 9.15
High: 9.42 Low: 8.57
Volume: 536,497 Market Cap: 288M
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.428 - 9.475 9.475 - 9.506
Low: 8.464 - 8.523 8.523 - 8.561
Close: 8.872 - 8.965 8.965 - 9.024

Technical analysis

as of: 2020-11-29 9:20:15 AM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.00     One year: 12.85
Support: Support1: 6.62    Support2: 4.89
Resistance: Resistance1: 9.42    Resistance2: 11.00
Pivot: 6.61
Moving Average: MA(5): 8.13     MA(20): 6.27
MA(100): 5.38     MA(250): 5.38
MACD: MACD(12,26): 0.76     Signal(9): 0.41
Stochastic oscillator: %K(14,3): 94.86     %D(3): 94.64
RSI: RSI(14): 84.62
52-week: High: 9.42  Low: 2.16  Change(%): 43.1
Average Vol(K): 3-Month: 41533  10-Days: 49939

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CRMD has closed below upper band by 2.0%. Bollinger Bands are 239.5% wider than normal. The large width of the bands suggest high volatility as compared to CRMD's normal range. The bands have been in this wide range for 5 bars. This is a sign that the current trend might continue.

Headline News

Sat, 28 Nov 2020
Is CorMedix Inc. (NYSE:CRMD) Potentially Life-Changing Stock? - Marketing Sentinel

Wed, 25 Nov 2020
Should You Buy CorMedix Inc. (CRMD) Stock? - InvestorsObserver

Sat, 21 Nov 2020
How is the CorMedix Inc. (NYSE:CRMD) performance outlook for the coming months? - Marketing Sentinel

Wed, 18 Nov 2020
CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed - Yahoo Finance

Fri, 13 Nov 2020
CorMedix: Patent Coverage Is A Problem - Seeking Alpha

Mon, 09 Nov 2020
Should You Buy CorMedix Inc. (CRMD) Stock on Monday? - InvestorsObserver

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 31
Shares Float (M) 29
% Held by Insiders 2.12
% Held by Institutions 24.72
Shares Short (K) 3,570
Shares Short P. Month (K) 3,640

Stock Financials

EPS -1.850
EPS Est This Year -0.530
EPS Est Next Year -0.280
Book Value (p.s.) 0.710
Profit Margin
Operating Margin -14347.16
Return on Assets (ttm) -60.5
Return on Equity (ttm) -113.8
Qtrly Rev. Growth -53.4
Gross Profit (p.s.) -0.003
Sales Per Share 0.006
EBITDA (p.s.) -0.801
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -13

Stock Valuations

PE Ratio -4.84
PEG Ratio
Price to Book value 12.62
Price to Sales 1601.23
Price to Cash Flow -16.89

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.